Early Survivorship Care Linked to Better Cancer Outcomes

A retrospective study found head and neck cancer patients who attended early survivorship care adhered more often to radiotherapy and fared better over three years.

Updated on Nov. 3, 2026 in Cancer

Isometric editorial illustration of a single radiotherapy treatment gantry and couch in a clean, pale treatment room, in muted cream, slate, and teal. — A retrospective study of 471 head and neck cancer patients found those attending early survivorship care at the University of Pittsburgh adhered better to radiotherapy and fared better over three years. AI Illustration. Upload story photo >

Patients with head and neck cancer who attended early multidisciplinary survivorship care were less likely to skip radiotherapy and had lower recurrence risk and better disease-free survival, according to a study published October 22 in JAMA Otolaryngology-Head & Neck Surgery. The retrospective cohort included 471 patients, of whom 31.4 percent received the early care.

Why it matters

Radiotherapy nonadherence is a known threat to cancer treatment success, and the findings point to supportive care as a possible lever. Clinicians and health systems across the United States are weighing how to structure survivorship services for patients completing curative treatment.

The study followed 471 patients, with 52.4 percent adhering to radiotherapy and attendees showing a 0.45 odds ratio for nonadherence. Because it is a retrospective design, the associations cannot establish that the care itself caused the improvements.

The players

University of Pittsburgh School of Medicine

A medical school in Pittsburgh, Pennsylvania, affiliated with the University of Pittsburgh and home to research programs in oncology and head and neck surgery.

JAMA Otolaryngology-Head & Neck Surgery

A peer-reviewed medical journal published by the American Medical Association that covers ear, nose, throat, and head and neck surgery research.

The details

Researchers at the University of Pittsburgh School of Medicine reviewed patients diagnosed with head and neck cancer who completed definitive curative-intent radiotherapy between March 2018 and March 2025. A multivariable analysis adjusting for clinical and sociodemographic factors compared outcomes between those who attended early survivorship care and those who did not.

March 21, 2018 to March 25, 2025: Patients in the cohort were diagnosed and completed radiotherapy.
October 22, 2026: The study was published online in JAMA Otolaryngology-Head & Neck Surgery.
November 3, 2026: HealthDay News reported on the study.

Roadmap

Survivorship care plans have been promoted nationally as a way to bridge the gap between completing cancer treatment and long-term follow-up. This study adds head and neck cancer-specific evidence that early engagement with such care may affect whether patients finish radiotherapy.

Patients finishing radiotherapy for head and neck cancer may ask their care teams whether early survivorship services are available to them. The findings suggest that engaging with follow-up support soon after treatment could help patients stay on schedule with radiation.

The takeaway

Early connection to multidisciplinary survivorship support may help head and neck cancer patients complete radiotherapy and reduce recurrence risk. Patients who face barriers to completing treatment should raise them with their care team early.